Genomatica: 15 Year Journey (and counting) | AIChE

Genomatica: 15 Year Journey (and counting)

Type

Conference Presentation

Conference Type

Metabolic Engineering Conference

Presentation Date

June 15, 2014

Duration

1 hour

Skill Level

Intermediate

As a founder and CEO, Christophe Schilling has led Genomatica from a developer of metabolic engineering tools to a position of leadership in biotech processes for the production of major chemicals – with multiple customers, $125 million in equity investments, and numerous awards for their technology, commercialization results and corporate culture.

Please join Christophe as he takes you on a 15 year (and counting) personal tour of his experiences. How did Genomatica go from pioneers in the commercial application of computational modeling of metabolism for the life sciences to the choice of a specific business strategy focused on developing and licensing process technology for chemical production, and the addition of experimental capabilities, process engineering and other core strengths? Christophe will speak to the technical, business and people issues that come up when starting with an idea, building a company, raising money, getting customers, and more. He’ll also share his personal view of where metabolic engineering can ‘most readily’turn into economic value – and what it takes to do so.

Presenter(s) 

Christophe Schilling

Christophe founded Geno in 1998, and served as CEO from May 2009 until December 2024, during which he led Geno’s mission to accelerate the transition to more sustainable materials, turning vision into reality - creating, scaling and commercializing multiple award-winning technologies delivering measurable impact across the US, Europe, and Asia on an economically competitive basis to fossil fuel based alternatives. Today he serves Geno in an active and engaged Founder capacity supporting strategic growth initiatives, while also serving as Chairman of the Board of Future Origins, a...Read more

Language